Chemoinformaics analysis of (3R)-3-[(1S,4R)-4-METHYL-1-(2-METHYLPROPANOYL)-3-OXOCYCLOHEXYL]BUTANOIC ACID
Molecular Weight | 268.353 | nRot | 5 |
Heavy Atom Molecular Weight | 244.161 | nRig | 9 |
Exact Molecular Weight | 268.167 | nRing | 1 |
Solubility: LogS | -1.794 | nHRing | 0 |
Solubility: LogP | 1.72 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 44.261 |
nHD | 1 | BPOL | 26.681 |
QED | 0.832 |
Synth | 4.12 |
Natural Product Likeliness | 1.448 |
NR-PPAR-gamma | 0.64 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.01 |
Pgp-sub | 0.001 |
HIA | 0.011 |
CACO-2 | -5.04 |
MDCK | 0.0000296 |
BBB | 0.079 |
PPB | 0.878408 |
VDSS | 0.183 |
FU | 0.157402 |
CYP1A2-inh | 0.01 |
CYP1A2-sub | 0.417 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.888 |
CYP2c9-inh | 0.011 |
CYP2c9-sub | 0.944 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.256 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.172 |
CL | 14.868 |
T12 | 0.89 |
hERG | 0.002 |
Ames | 0.021 |
ROA | 0.293 |
SkinSen | 0.039 |
Carcinogencity | 0.033 |
EI | 0.069 |
Respiratory | 0.05 |
NR-Aromatase | 0.014 |
Antiviral | Yes |
Prediction | 0.918752 |